# Sevoflurane

## Sojourn Inhalation Liquid 250mL/bottle

| 藥物代碼 | ESOJ |
| :--- | :--- |
| 適應症 | Induction and maintenance of general anesthesia in adults and pediatric patients for inpatient and outpatient surgery. |
| 副作用 | &gt;10%:Cardiovascular: Hypotension \(4% to 11%; dose-dependent\)Central nervous system: Agitation \(7% to 15%\)Gastrointestinal: Nausea \(25%\), vomiting \(18%\)Respiratory: Cough \(5% to 11%\)1% to 10%:Cardiovascular: Tachycardia \(2% to 6%\), bradycardia \(5%\), hypertension \(2%\)Central nervous system: Drowsiness \(9%\), shivering \(6%\), dizziness \(4%\), headache \(1%\), hypothermia \(1%\), myoclonus \(1%\), delirium \(emergence\)Gastrointestinal: Sialorrhea \(2% to 4%\)Respiratory: Airway obstruction \(8%\), laryngospasm \(2% to 8%\), breath-holding \(2% to 5%\), apnea \(2%\)Miscellaneous: Fever \(1%\) |
| 禁忌 | Hypersensitivity to sevoflurane, other halogenated anesthetics, or any component of the formulation; known or suspected susceptibility to malignant hyperthermia. |
| 藥物保存方式 | 15-30°C |
| 用法用量 | Individualized dosage. Adult Anesthesia: Inhalation: Surgical levels of anesthesia are generally achieved with concentrations from 0.5% to 3% with or without the concomitant use of nitrous oxide; the concentration at which amnesia and loss of awareness occur is 0.6%. MAC values for surgical levels of anesthesia: \(25 years\) Sevoflurane in oxygen: 2.6%, Sevoflurane in 65% N20/35% oxygen: 1.4% \(40 years\) Sevoflurane in oxygen: 2.1%, Sevoflurane in 65% N20/35% oxygen: 1.1% \(60 years\) Sevoflurane in oxygen: 1.7%, Sevoflurane in 65% N20/35% oxygen: 0.9% \(80 years\) Sevoflurane in oxygen: 1.4%, Sevoflurane in 65% N20/35% oxygen: 0.7% Pediatric Anesthesia: Inhalation: Surgical levels of anesthesia are generally achieved with concentrations from 0.5% to 3% with or without the concomitant use of nitrous oxide; the concentration at which amnesia and loss of awareness occur is 0.6%. MAC values for surgical levels of anesthesia: \(0 to 1 month old full-term neonates\) Sevoflurane in oxygen: 3.3% \(1 to &lt;6 months\) Sevoflurane in oxygen: 3% \(6 months to &lt;1 year\) Sevoflurane in oxygen: 2.8%, Sevoflurane in 65% N20/35% oxygen: 2% \(1 to &lt;3 years\) Sevoflurane in oxygen: 2.8%, Sevoflurane in 60% N20/40% oxygen: 2% \(3-12 years\) Sevoflurane in oxygen: 2.5% |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest low risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IH |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

